Anti-CANT1 Polyclonal Antibody
Anti-CANT1 Polyclonal Antibody应用 WB 稀释比例 WB 1:5000-8000. 交叉反应 Human
干扰素相关发育调节因子2抗体
FLJ40446; IFNRP; IFRD 2; IFRD2; IFRD2_HUMAN; Interferon related developmental regulator 2; Interferon related protein; Interferon-related developmental regulator 2; Protein SKMC15; SKMc 15; SKMc15; SK
Anti-ADRA1A Polyclonal Antibody
Anti-ADRA1A Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human
Anti-KRT17 Mouse Monoclonal Antibody
Anti-KRT17 Monoclonal Antibody 应用WB IHC IF 稀释比例 WB 1:1000. IHC 1:200. IP 1:200.交叉反应 Human
肿瘤坏死因子配体超家族成员12抗体
CD 255; CD255; APO 3 ligand; APO 3L; APO3 ligand; APO3/DR3 ligand; APO3L; DR3LG; MGC129581; MGC20669; secreted form; TNF related weak inducer of apoptosis; TNF-related weak inducer of apoptosis; TNF12
1号染色体开放阅读框182抗体
C1orf182; CA182_HUMAN; SSTK-interacting protein; SSTK-IP; Uncharacterized protein C1orf182.
1号染色体开放阅读框189抗体
Chromosome 1 open reading frame 189; Uncharacterized protein C1orf189; CA189_HUMAN.
1号染色体开放阅读框54抗体
Chromosome 1 open reading frame 54; FLJ23221; Hypothetical protein LOC79630; Uncharacterized protein C1orf54; CA054_HUMAN.
半胱氨酸蛋白酶抑制剂11抗体
Cst11; CST11_HUMAN; CST8L; cystatin 11; cystatin related epididymal specific protein; Cystatin-11; dJ322G13.6; SC13; SC13delta.